Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1629-1641
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1629
Table 1 Indication, advantages, and disadvantages of existing approaches to induce liver remnant hypertrophy before major liver resection
Approach
Indication
Advantage
Disadvantage
PVEInsufficient FLR volumePercutaneous approachContraindicated in patients with extensive portal thrombus and important portal hypertension; Could promote tumoral growth within the embolized liver
PVL and two-stage hepatectomyInsufficient FLR volume and treatment of bilobar liver diseasePVL is performed during the first surgical step (tumoral clearance of the FLR)Surgical procedure; Morbidity
Associating liver partition and PVL for staged hepatectomy Insufficient FLR volume +/- treatment of bilobar liver diseaseLiver surgery is performed in a short period of time (15 d); First surgical step (PVL and in situ splitting of the liver parenchyma) can be associated with tumoral clearance of the FLRSurgical procedure; Morbidity
Sequential trans arterial embolization and PVEInsufficient FLR volume in patients with hepatocellular carcinomaPercutaneous approachMay help to counteract the stimulating effect of PVE on tumor growthSequential approach (two procedures) is recommended to limit the risk of nontumoral liver ischemic necrosis; Contraindicated in patients with extensive portal thrombus, important portal hypertension or previous biliary surgery (biliodigestive anastomosis)
Liver venous deprivationInsufficient FLR volumePercutaneous approachContraindicated in patients with extensive portal thrombus and important portal hypertension; Could promote tumoral growth within the embolized liver
RLInsufficient FLR volumePercutaneous approachConcomitant tumoral control and FLR increaseCan be carried out in patients with portal vein thrombosisData reporting liver resection after RL is scarce